Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilin Tang

Showing results (71-80 of 344) with videos related to

Pageof 35
Sort By:
Clinical Lung Cancer|December 8, 2020
MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung CancerWei Yin, Joanne Cheng, Zhenya Tang, et al.
Annals of Hematology|May 21, 2017
Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyZimu Gong, Lan Zheng, Zhenya Tang, et al.
American Journal of Hematology|May 27, 2025
ALK+ Large B-Cell Lymphoma With Novel ZNF296::ALK: A Morphologic Mimic of ALK+ Anaplastic Large Cell LymphomaWei J Wang, Pei Lin, John M Stewart, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2021
Concurrent TP53 Mutation and Deletion in Refractory Low-grade Follicular LymphomaMahsa Khanlari, Sa A Wang, Nathan H Fowler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2011
Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaYi Zhou, Guilin Tang, L Jeffrey Medeiros, et al.
Annals of Hematology|December 5, 2016
Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyZimu Gong, Lan Zheng, Zhenya Tang, et al.
Cancer Genetics|June 20, 2016
Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotypeYang O Huh, Guilin Tang, Sameer S Talwalkar, et al.
Cancers|January 8, 2025
Detection of <i>KMT2A</i> Partial Tandem Duplication by Optical Genome Mapping in Myeloid Neoplasms: Associated Cytogenetics, Gene Mutations, Treatment Responses, and Patient OutcomesQing Wei, Shimin Hu, Jie Xu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2017
Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinomaZhenya Tang, Jianjun Zhang, Xinyan Lu, et al.
Molecular Cytogenetics|August 11, 2016
Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticistsZhenya Tang, L Jeffrey Medeiros, C Cameron Yin, et al.
Pageof 35

Showing results (71-80 of 344) with videos related to

Sort By:
Pageof 35
Clinical Lung Cancer|December 8, 2020
MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung CancerWei Yin, Joanne Cheng, Zhenya Tang, et al.
Annals of Hematology|May 21, 2017
Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyZimu Gong, Lan Zheng, Zhenya Tang, et al.
American Journal of Hematology|May 27, 2025
ALK+ Large B-Cell Lymphoma With Novel ZNF296::ALK: A Morphologic Mimic of ALK+ Anaplastic Large Cell LymphomaWei J Wang, Pei Lin, John M Stewart, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2021
Concurrent TP53 Mutation and Deletion in Refractory Low-grade Follicular LymphomaMahsa Khanlari, Sa A Wang, Nathan H Fowler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2011
Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaYi Zhou, Guilin Tang, L Jeffrey Medeiros, et al.
Annals of Hematology|December 5, 2016
Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyZimu Gong, Lan Zheng, Zhenya Tang, et al.
Cancer Genetics|June 20, 2016
Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotypeYang O Huh, Guilin Tang, Sameer S Talwalkar, et al.
Cancers|January 8, 2025
Detection of <i>KMT2A</i> Partial Tandem Duplication by Optical Genome Mapping in Myeloid Neoplasms: Associated Cytogenetics, Gene Mutations, Treatment Responses, and Patient OutcomesQing Wei, Shimin Hu, Jie Xu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2017
Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinomaZhenya Tang, Jianjun Zhang, Xinyan Lu, et al.
Molecular Cytogenetics|August 11, 2016
Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticistsZhenya Tang, L Jeffrey Medeiros, C Cameron Yin, et al.
Pageof 35